108 related articles for article (PubMed ID: 16720979)
1. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.
Kelly HR; Urbanski M; Burda S; Zhong P; Konings F; Nanfack J; Tongo M; Kinge T; Achkar J; Nyambi P
Hum Antibodies; 2005; 14(3-4):89-99. PubMed ID: 16720979
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
[TBL] [Abstract][Full Text] [Related]
3. Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
Bunnik EM; Lobbrecht MS; van Nuenen AC; Schuitemaker H
Virology; 2010 Feb; 397(1):224-30. PubMed ID: 19945135
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects.
Cecilia D; Kleeberger C; Muñoz A; Giorgi JV; Zolla-Pazner S
J Infect Dis; 1999 Jun; 179(6):1365-74. PubMed ID: 10228056
[TBL] [Abstract][Full Text] [Related]
5. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
Bradney AP; Scheer S; Crawford JM; Buchbinder SP; Montefiori DC
J Infect Dis; 1999 May; 179(5):1264-7. PubMed ID: 10191234
[TBL] [Abstract][Full Text] [Related]
6. Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
Marcelino JM; Borrego P; Nilsson C; Família C; Barroso H; Maltez F; Doroana M; Antunes F; Quintas A; Taveira N
AIDS; 2012 Nov; 26(18):2275-84. PubMed ID: 23151495
[TBL] [Abstract][Full Text] [Related]
7. Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.
Bunnik EM; van Gils MJ; Lobbrecht MS; Pisas L; van Nuenen AC; Schuitemaker H
Virology; 2009 Aug; 390(2):348-55. PubMed ID: 19539340
[TBL] [Abstract][Full Text] [Related]
8. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
9. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
[TBL] [Abstract][Full Text] [Related]
10. Stable biological and antigenic characteristics of HIV-2SBL6669 in nonpathogenic infection of macaques.
Zhang YJ; Putkonen P; Albert J; Ohman P; Biberfeld G; Fenyö EM
Virology; 1994 May; 200(2):583-9. PubMed ID: 7909969
[TBL] [Abstract][Full Text] [Related]
11. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
[TBL] [Abstract][Full Text] [Related]
12. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
Cagigi A; Nilsson A; De Milito A; Chiodi F
Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
[TBL] [Abstract][Full Text] [Related]
13. Inter-subtype cross-neutralizing antibodies recognize epitopes on cell-associated HIV-1 virions.
Donners H; Davis D; Willems B; van der Groen G
J Med Virol; 2003 Feb; 69(2):173-81. PubMed ID: 12683404
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
15. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.
Deeks SG; Schweighardt B; Wrin T; Galovich J; Hoh R; Sinclair E; Hunt P; McCune JM; Martin JN; Petropoulos CJ; Hecht FM
J Virol; 2006 Jun; 80(12):6155-64. PubMed ID: 16731954
[TBL] [Abstract][Full Text] [Related]
17. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
[TBL] [Abstract][Full Text] [Related]
18. Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O.
Nkengasong JN; Fransen K; Willems B; Karita E; Vingerhoets J; Kestens L; Colebunders R; Piot P; van der Groen G
J Med Virol; 1997 Mar; 51(3):202-9. PubMed ID: 9139084
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
[TBL] [Abstract][Full Text] [Related]
20. Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies.
Rademeyer C; Moore PL; Taylor N; Martin DP; Choge IA; Gray ES; Sheppard HW; Gray C; Morris L; Williamson C;
Virology; 2007 Nov; 368(1):172-81. PubMed ID: 17632196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
